BioPixS creates innovative tissue mimicking phantoms and standardisation methods for biophotonics applications. These phantoms are stand-ins for human tissues that simulate the interaction of light with tissue, thus reducing time and cost of developing high-tech biomedical devices. They also target the reduction of animal use in pre-clinical trials, providing parallel alternatives. These innovations are set to transform the way biophotonics research is performed by providing solutions that accelerate instrument development and standardisation and monitor day-to-day performance of current devices.
The company spun out of the Tyndall National Institute in Cork and the Innovation Office at UCC was involved from the outset, providing support in identifying, assessing, capturing and managing IP, as well as negotiating licence agreements. In addition, the office has supported the company’s funding submissions, facilitated introductions to investors and advised on business strategy.
BioPixS leases lab space at Tyndall to carry out some of its research and is involved in a number of research consortia with leading universities, technology companies and hospitals globally. The company currently has customers in 9 countries worldwide and is in the process of testing the market for its range of products with plans to launch further products in 2023.
• SCIENCE FOUNDATION IRELAND - IRISH PHOTONIC INTEGRATION CENTRE (IPIC)
"The Innovation Office at UCC has championed the growth of BioPixS on multiple fronts, including introducing us to investors, providing valuable strategy advice and networking opportunities, and by supporting our growth requirements inside UCC and beyond." - Dr Sanathana Konugolu, CEO, BioPixS
Published: 2022
Find out more about working with third-level research